AbolerIS Pharma
PrivateLast Round
Series A
Sep 18, 2023
Total Funding Raised
$32.1M
Company Overview
AbolerIS Pharma is a biotechnology company that develops novel immunomodulatory antibodies to induce immune tolerance for treating inflammatory, autoimmune, and degenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AbolerIS Pharma Comparables
Compare AbolerIS Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Revolo Biotherapeutics | 76% | |
| NXI Therapeutics | 75% | |
| UCB | 74% |
AbolerIS Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 18, 2023 | ||||
| Seed | Nov 4, 2020 |
AbolerIS Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series A |
| Newton Biocapital | Seed, Series A |
| Wallonie Entreprendre | Series A |
| Criteria Capital Risc | Series A |
| Sambrinvest | Series A |
| Sound Bioventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2025
Philippe Alen appointed as the new Chief Business Officer.
- Sep 18, 2023
$29.1M round led by Caixa Capital Risc
AbolerIS Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AbolerIS Pharma's valuation, stock price, and market status.
Is AbolerIS Pharma a public or private company?
AbolerIS Pharma is a private company.
What is the current stock price of AbolerIS Pharma?
AbolerIS Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is AbolerIS Pharma worth (valuation)?
Valuation information for AbolerIS Pharma is not publicly available.
Can I buy AbolerIS Pharma stock?
AbolerIS Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AbolerIS Pharma's last funding round?
AbolerIS Pharma's most recent funding round was Series A on September 18, 2023.
Who are the main investors in AbolerIS Pharma?
Key investors in AbolerIS Pharma include Caixa Capital Risc.
Will AbolerIS Pharma IPO soon?
No public IPO plans have been announced for AbolerIS Pharma.
How can I track AbolerIS Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AbolerIS Pharma's secondary market activity and sign up for updates.